Citation: Er. Butelman et al., CLOCINNAMOX ANTAGONISM OF OPIOID SUPPRESSION OF SCHEDULE-CONTROLLED RESPONDING IN RHESUS-MONKEYS, Psychopharmacology, 123(4), 1996, pp. 320-324
Citation: G. Zernig et al., CALCULATION OF AGONIST EFFICACY, APPARENT AFFINITY, AND RECEPTOR POPULATION-CHANGES AFTER ADMINISTRATION OF INSURMOUNTABLE ANTAGONISTS - COMPARISON OF DIFFERENT ANALYTICAL APPROACHES, Journal of pharmacological and toxicological methods, 35(4), 1996, pp. 223-237
Authors:
DERRICK I
MOYNIHAN HA
BROADBEAR J
WOODS JH
LEWIS JW
Citation: I. Derrick et al., 6N-CINNAMOYL-BETA-NALTREXAMINE AND ITS P-NITRO DERIVATIVE - HIGH EFFICACY KAPPA-OPIOID AGONISTS WITH WEAK ANTAGONIST ACTIONS, Bioorganic & medicinal chemistry letters, 6(2), 1996, pp. 167-172
Citation: G. Winger et Jh. Woods, EFFECTS OF BUPRENORPHINE ON BEHAVIOR MAINTAINED BY HEROIN AND ALFENTANIL IN RHESUS-MONKEYS, Behavioural pharmacology, 7(2), 1996, pp. 155-159
Authors:
ACTEO MD
BOWMAN E
BUTELMAN E
ENGLISH JA
HARRIS L
JACOBSON AE
MATTSON MV
MEDZIHRADSKY F
PATRICK G
ROWLETT JK
SMITH CB
WINGER G
WOODS JH
WOOLVERTON WL
Citation: Md. Acteo et al., ZIPEPROL - PRECLINICAL ASSESSMENT OF ABUSE POTENTIAL, Drug and alcohol dependence, 42(2), 1996, pp. 93-104
Citation: Rl. Shortt et al., INBREEDING EFFECTS ON THE SPRING FROST HARDINESS OF COASTAL DOUGLAS-FIR, Canadian journal of forest research, 26(6), 1996, pp. 1049-1054
Authors:
DERRICK I
LEWIS JW
MOYNIHAN HA
BROADBEAR J
WOODS JH
Citation: I. Derrick et al., POTENTIAL IRREVERSIBLE LIGANDS FOR OPIOID RECEPTORS - CINNAMOYL DERIVATIVES OF BETA-NALTREXAMINE, Journal of Pharmacy and Pharmacology, 48(2), 1996, pp. 192-196
Citation: J. Yu et al., IN-VITRO BIOTRANSFORMATION OF DYNORPHIN A(1-17) IS SIMILAR IN HUMAN AND RHESUS-MONKEY BLOOD AS STUDIED BY MATRIX-ASSISTED LASER-DESORPTION IONIZATION MASS-SPECTROMETRY, The Journal of pharmacology and experimental therapeutics, 279(2), 1996, pp. 507-514
Citation: Er. Butelman et al., METHOCLOCINNAMOX - AGONIST AND ANTAGONIST EFFECTS OF A NOVEL LONG-LASTING OPIOID IN RHESUS-MONKEYS, The Journal of pharmacology and experimental therapeutics, 279(2), 1996, pp. 934-938
Citation: G. Zernig et al., MECHANISM OF CLOCINNAMOX BLOCKADE OF OPIOID RECEPTORS - EVIDENCE FROMIN-VITRO AND EX-VIVO BINDING AND BEHAVIORAL ASSAYS, The Journal of pharmacology and experimental therapeutics, 279(1), 1996, pp. 23-31
Authors:
EMMERSON PJ
CLARK MJ
MANSOUR A
AKIL H
WOODS JH
MEDZIHRADSKY F
Citation: Pj. Emmerson et al., CHARACTERIZATION OF OPIOID AGONIST EFFICACY IN A C-6 GLIOMA CELL-LINEEXPRESSING THE MU-OPIOID RECEPTOR, The Journal of pharmacology and experimental therapeutics, 278(3), 1996, pp. 1121-1127
Citation: Dc. Jewett et al., NITRIC-OXIDE SYNTHASE INHIBITORS PRODUCE PHENCYCLIDINE-LIKE BEHAVIORAL-EFFECTS IN PIGEONS, Brain research, 715(1-2), 1996, pp. 25-31
Citation: Sp. Baron et Jh. Woods, COMPETITIVE AND UNCOMPETITIVE N-METHYL-D-ASPARTATE ANTAGONIST DISCRIMINATIONS IN PIGEONS - CGS-19755 AND PHENCYCLIDINE, Psychopharmacology, 118(1), 1995, pp. 42-51
Citation: Cm. Campbell et al., L-ARGININE REVERSAL OF BEHAVIORAL DEFICITS PRODUCED BY PHENCYCLIDINE AND CGS-19755, Behavioural pharmacology, 6(5-6), 1995, pp. 617-617
Authors:
ZERNIG G
ISSAEVITCH T
BROADBEAR JH
BURKE TF
LEWIS JW
BRINE GA
WOODS JH
Citation: G. Zernig et al., RECEPTOR RESERVE AND AFFINITY OF MU-OPIOID AGONISTS IN MOUSE ANTINOCICEPTION - CORRELATION WITH RECEPTOR-BINDING, Life sciences, 57(23), 1995, pp. 2113-2125
Citation: Er. Butelman et al., AGONIST AND ANTAGONIST EFFECTS OF DYNORPHIN A-(1-13) IN A THERMAL ANTINOCICEPTION ASSAY IN RHESUS-MONKEYS, The Journal of pharmacology and experimental therapeutics, 275(1), 1995, pp. 374-380